Newman Dignan & Sheerar, Inc. Pfizer Inc Transaction History

Newman Dignan & Sheerar, Inc.

$386 Million
Q4 2024

A detailed history of Newman Dignan & Sheerar, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Newman Dignan & Sheerar, Inc. holds 17,435 shares of PFE stock, worth $458,540. This represents 0.12% of its overall portfolio holdings.

Number of Shares

17,435

Previous 18,141 3.89%

Holding current value

$458,540

Previous $525,000 12.0%

% of portfolio

0.12%

Previous 0.09%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 30, 2025	SELL	$24.8 - $30.19 $17,508 - $21,314	-706 Reduced 3.89%	17,435 $462,000
Q3 2024 Nov 12, 2024	SELL	$27.7 - $31.39 $37,118 - $42,062	-1,340 Reduced 6.88%	18,141 $525,000
Q2 2024 Jul 15, 2024	SELL	$25.26 - $29.6 $18,439 - $21,608	-730 Reduced 3.61%	19,481 $545,000
Q1 2024 Apr 26, 2024	SELL	$25.89 - $29.73 $86,394 - $99,209	-3,337 Reduced 14.17%	20,211 $560,000
Q4 2023 Feb 08, 2024	SELL	$26.13 - $33.94 $203,239 - $263,985	-7,778 Reduced 24.83%	23,548 $677,000
Q3 2023 Nov 07, 2023	SELL	$32.09 - $37.51 $45,439 - $53,114	-1,416 Reduced 4.32%	31,326 $1.04 Million
Q2 2023 Aug 02, 2023	BUY	$36.12 - $41.79 $325 - $376	9 Added 0.03%	32,742 $1.2 Million
Q1 2023 Apr 28, 2023	SELL	$39.39 - $51.28 $3,584 - $4,666	-91 Reduced 0.28%	32,733 $1.34 Million
Q4 2022 Jan 20, 2023	SELL	$41.75 - $54.5 $28,891 - $37,714	-692 Reduced 2.06%	32,824 $0
Q3 2022 Oct 18, 2022	BUY	$43.76 - $53.42 $11,858 - $14,476	271 Added 0.82%	33,516 $1.47 Million
Q2 2022 Aug 03, 2022	SELL	$46.53 - $55.17 $13,261 - $15,723	-285 Reduced 0.85%	33,245 $1.74 Million
Q1 2022 Apr 14, 2022	SELL	$45.75 - $56.69 $11,254 - $13,945	-246 Reduced 0.73%	33,530 $1.74 Million
Q4 2021 Jan 18, 2022	BUY	$41.32 - $61.25 $123 - $183	3 Added 0.01%	33,776 $1.99 Million
Q3 2021 Oct 07, 2021	SELL	$39.25 - $50.42 $5,848 - $7,512	-149 Reduced 0.44%	33,773 $1.45 Million
Q2 2021 Jul 28, 2021	BUY	$35.91 - $40.68 $118,395 - $134,121	3,297 Added 10.77%	33,922 $1.33 Million
Q1 2021 May 05, 2021	SELL	$33.49 - $37.77 $67,884 - $76,559	-2,027 Reduced 6.21%	30,625 $1.11 Million
Q4 2020 Jan 29, 2021	BUY	$33.47 - $42.56 $267 - $340	8 Added 0.02%	32,652 $1.2 Million
Q3 2020 Oct 14, 2020	BUY	$31.75 - $37.25 $15,875 - $18,625	500 Added 1.56%	32,644 $1.2 Million
Q2 2020 Aug 06, 2020	BUY	$30.12 - $36.54 $53,041 - $64,346	1,761 Added 5.8%	32,144 $1.25 Million
Q1 2020 Apr 20, 2020	SELL	$27.03 - $38.62 $20,056 - $28,656	-742 Reduced 2.38%	30,383 $1.09 Million
Q4 2019 Jan 15, 2020	BUY	$32.92 - $37.36 $34,566 - $39,228	1,050 Added 3.49%	31,125 $1.22 Million
Q3 2019 Oct 21, 2019	SELL	$32.49 - $42.13 $380,295 - $493,131	-11,705 Reduced 28.02%	30,075 $1.08 Million
Q2 2019 Jul 31, 2019	SELL	$36.98 - $41.52 $24,998 - $28,067	-676 Reduced 1.59%	41,780 $1.81 Million
Q1 2019 Apr 09, 2019	SELL	$37.5 - $41.2 $6,900 - $7,580	-184 Reduced 0.43%	42,456 $1.8 Million
Q4 2018 Jan 24, 2019	BUY	$38.47 - $43.86 $21,927 - $25,000	570 Added 1.35%	42,640 $1.86 Million
Q3 2018 Oct 25, 2018	BUY	$34.47 - $41.81 $4,170 - $5,059	121 Added 0.29%	42,070 $1.89 Million
Q2 2018 Jul 06, 2018	SELL	$32.98 - $35.16 $30,572 - $32,593	-927 Reduced 2.16%	41,949 $1.52 Million
Q1 2018 Apr 17, 2018	SELL	$31.91 - $37.02 $82,519 - $95,733	-2,586 Reduced 5.69%	42,876 $1.56 Million
Q4 2017 Jan 29, 2018	BUY	$33.26 - $35.29 $12,805 - $13,586	385 Added 0.85%	45,462 $1.65 Million
Q3 2017 Oct 18, 2017	BUY	$31.0 - $34.15 $434 - $478	14 Added 0.03%	45,077 $1.61 Million
Q2 2017 Aug 08, 2017	BUY	N/A	45,063	45,063 $1.51 Million

Others Institutions Holding PFE

# of Institutions

3,354

Shares Held

3.69B

Call Options Held

106M

Put Options Held

123M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Newman Dignan & Sheerar, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Newman Dignan & Sheerar, Inc. with notifications on news.

Account

Newman Dignan & Sheerar, Inc. Pfizer Inc Transaction History